Robinson WilliamÂ
Biochemistry
Primal Therapies
United States of America
Biography
Bill Robinson is a co-founder of Primal Therapies, Inc. and Atreca, a privately held biotechnology company developing novel therapeutics based on a deep understanding of the human immune response. He’s also currently an Associate Professor of Medicine in the Department of Immunology and Rheumatology at Stanford University. Dr. Robinson is also the the Director of the Stanford Osteoarthritis Initiative and a co-lead of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network of the NIH. Bill Robinson is a co-founder of Primal Therapies, Inc. and Atreca, a privately held biotechnology company developing novel therapeutics based on a deep understanding of the human immune response. He’s also currently an Associate Professor of Medicine in the Department of Immunology and Rheumatology at Stanford University. Dr. Robinson is also the the Director of the Stanford Osteoarthritis Initiative and a co-lead of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network of the NIH.
Research Interest
Biochemistry